According to WebProNews, OpenEvidence, a startup specializing in AI-driven healthcare solutions, recently finalized a substantial equity financing round worth $250 million. This influx of capital has catapulted the company's post-investment valuation to an impressive $12 billion, marking a twofold increase from just two months prior. OpenEvidence boasts an annualized advertising revenue stream nearing $150 million, coupled with a gross margin that surpasses 90%. Its innovative products have garnered the endorsement of nearly half of the medical practitioners across the United States, reflecting a strong market penetration and trust within the healthcare community.
